$Beam Ther_老虎社区_美港股上老虎

换汤不换药
2020-12-31

$Beam Therapeutics, Inc.(BEAM)$$CRISPR Therapeutics AG(CRSP)$$Editas Medicine, Inc.(EDIT)$碱基编辑技术作为CRISPR的升级版，可以更精准的实现基因编辑，同时避免DNA双链断裂带来的问题，未来应用的前景十分广阔。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":331036170,"tweetId":"331036170","gmtCreate":1609386271890,"gmtModify":1703739133250,"author":{"id":3496215943716304,"authorId":3496215943716304,"authorIdStr":"3496215943716304","name":"换汤不换药","avatar":"https://static.tigerbbs.com/7527881faee6e24547686baa58b87eea","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2121,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/BEAM\">$Beam Therapeutics, Inc.(BEAM)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/CRSP\">$CRISPR Therapeutics AG(CRSP)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/EDIT\">$Editas Medicine, Inc.(EDIT)$</a>碱基编辑技术作为CRISPR的升级版，可以更精准的实现基因编辑，同时避免DNA双链断裂带来的问题，未来应用的前景十分广阔。 </body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/BEAM\">$Beam Therapeutics, Inc.(BEAM)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/CRSP\">$CRISPR Therapeutics AG(CRSP)$</a><a target=\"_blank\" href=\"https://laohu8.com/S/EDIT\">$Editas Medicine, Inc.(EDIT)$</a>碱基编辑技术作为CRISPR的升级版，可以更精准的实现基因编辑，同时避免DNA双链断裂带来的问题，未来应用的前景十分广阔。 </body></html>","text":"$Beam Therapeutics, Inc.(BEAM)$$CRISPR Therapeutics AG(CRSP)$$Editas Medicine, Inc.(EDIT)$碱基编辑技术作为CRISPR的升级版，可以更精准的实现基因编辑，同时避免DNA双链断裂带来的问题，未来应用的前景十分广阔。","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/331036170","repostId":0,"isVote":1,"tweetType":3,"object":{"shareLink":"https://mp.weixin.qq.com/s?__biz=Mzg2NDQ3NDY3Ng==&tempkey=MTA5NF9oam1hSnlkZWpXSm80OTZrQ2kzSlJ3Ql9mY2loWGFvSkd6ZEJHaEdGWTdhZU1KcEFtUUZ1MlVJS1dYYm53ZUhvRGZOM3FaZlM3LWpvZ2VDOGxEdFRpVEM4dDZJblJYY2djRjhianUxUF9fcDktRHU0bnQ0bWxCbjh3akgxSnVWLWI0b3NBczJINWxlVkZUNzNkSFN2Ml9mWWtnWUtfd2VYS1VRdnJRfn4%3D&chksm=4e698116791e0800589d283f983660c3bec8e54da491d591451c4b3c1ef22071ac76ebdb3fd9#rd","poster":"https://mmbiz.qpic.cn/mmbiz_png/9B7iakJA2lCMOibdJTBYygWX01DRvoOGZltEo4eftsWYiaYluKuKL67bP6vTjNPkloYAhzyLH3Ea5TJcziaQzKvmwg/640?wx_fmt=png","title":"碱基编辑技术的开拓者—Beam Therapeutics"},"viewCount":2119,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CRSP","BEAM","EDIT"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":193,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}